플러스100%마이너스

  • 화면크기
통합검색

한의약융합데이터센터


근거중심한의약 DB

Home > 한의약융합데이터센터 > 근거중심한의약 DB
Title

A pilot controlled trial of a combination of dense cranial electroacupuncture stimulation and body acupuncture for post-stroke depression.

Authors

Man SC, Hung BH, Ng RM, Yu XC, Cheung H, Fung MP, Li LS, Leung KP, Leung KP, Tsang KW, Ziea E, Wong VT, Zhang ZJ.

Journal

BMC Complement Altern Med.

Year

2014

Vol (Issue)

14

Page

255

doi

10.1186/1472-6882-14-255.

PMID

25038733

Url

http://www.ncbi.nlm.nih.gov/pubmed/25038733

MeSH

Aged
Combined Modality Therapy
Depression/drug therapy
Depression/etiology
Depression/therapy*
Electroacupuncture/methods*
Female
Humans
Male
Middle Aged
Pilot Projects
Serotonin Uptake Inhibitors/therapeutic use
Single-Blind Method
Stroke/psychology*
Stroke/rehabilitation
Treatment Outcome

Keywords

Acupuncture; Post-stroke depression; Rehabilitation; Dense cranial electroacupuncture stimulation; DCEAS; Clinical trial

한글 키워드

침 치료; 뇌졸중 후 우울증; 재활; 고밀도 두개 전침 자극; 고밀도 두개 전침 자극; 임상 시험

KMCRIC
Summary & Commentary

KMCRIC 비평 보기 +

Korean Study

Abstract

BACKGROUND:
Our previous studies have demonstrated the treatment benefits of dense cranial electroacupuncture stimulation (DCEAS), a novel brain stimulation therapy in patients with major depression, postpartum depression and obsessive-compulsive disorder. The purpose of the present study was to further evaluate the effectiveness of DCEAS combined with body acupuncture and selective serotonin reuptake inhibitors (SSRIs) in patients with post-stroke depression (PSD).

METHODS:
In a single-blind, randomized controlled trial, 43 patients with PSD were randomly assigned to 12 sessions of DCEAS plus SSRI plus body electroacupuncture (n = 23), or sham (non-invasive cranial electroacupuncture, n-CEA) plus SSRI plus body electroacupuncture (n = 20) for 3 sessions per week over 4 weeks. Treatment outcomes were measured using the 17-item Hamilton Depression Rating Scale (HAMD-17), the Clinical Global Impression - Severity scale (CGI-S) and Barthel Index (BI), a measure used to evaluate movement ability associated with daily self-caring activity.

RESULTS:
DCEAS produced a significantly greater reduction of both HAMD-17 and CGI-S as early as week 1 and CGI-S at endpoint compared to n-CEA, but subjects of n-CEA group exhibited a significantly greater improvement on BI at week 4 than DCEAS. Incidence of adverse events was not different in the two groups.

CONCLUSIONS:
These results indicate that DCEAS could be effective in reducing stroke patients' depressive symptoms. Superficial electrical stimulation in n-CEA group may be beneficial in improving movement disability of stroke patients. A combination of DCEAS and body acupuncture can be considered a treatment option for neuropsychiatric sequelae of stroke.

TRIAL REGISTRATION:
http://www.clinicaltrials.gov, NCT01174394.

국문초록

Language

영어

첨부파일